Home Compare EMG.L vs PFE
Stock Comparison · Valuation-led comparison

Man Group vs Pfizer: Which Stock Looks Stronger in 2026?

The structural profiles are close, with Pfizer carrying a narrow edge on valuation. Man still has the edge on growth, which keeps the comparison from looking entirely one-sided. In the market, Man carries the stronger setup — intact trend against Pfizer's broken trend. That leaves a split case: the structural lead stays with Pfizer, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (EMG.L: STOXX 600, PFE: S&P 500).

Updated 2026-07-05

Most of the separation is still concentrated in valuation.

Trajectory Similarity
0.65
Moderately similar
Peer-set rank: #3
within Man Group Plc's functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

This level of similarity points to a meaningful structural match, though not a tight one.

Most of the shared profile comes through recent revenue growth and investment intensity.

Similarity drivers
recent revenue growthinvestment intensity
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
EMG.L
Man Group Plc
42
Peer-Score
Signal qualityMedium
Peer basis: STOXX 600
vs
PFE
Pfizer Inc.
47
Peer-Score
Signal qualityHigh
Peer basis: S&P 500

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Pricing shapes this comparison more than a broad operating gap.

Dimension spread: EMG.L vs PFE Profitability 16 16 Stability 58 49 Valuation 50 83 Growth 51 38 EMG.L PFE
Gap Ranking
#1 Valuation +33
#2 Growth +13
#3 Stability +9
#4 Profitability
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for EMG.L and PFE Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer EMG.LPFE Relative valuation Structural strength

Structure stays fairly close here, while current pricing still looks more supportive for Pfizer Inc..

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Valuation
Both rank well on valuation, but Pfizer Inc. still holds a clear edge.
Growth
Man Group Plc sits in the stronger part of the group on growth, while Pfizer Inc. is closer to mid-pack.
Valuation — Dominant Gap
EMG.L
50
PFE
83
Gap+33in favour of PFE

The multiple-based pricing edge comes from a trailing P/E that is 8.5 turns lower.

What keeps the gap from being one-sided

On the market side, Man carries the stronger trend while Pfizer's trend has broken — the market setup does not confirm the structural advantage.

What this means for the comparison

Valuation points more clearly to Pfizer Inc., but growth and current pricing keep the broader result mixed.

Explore full peer positioning in AssetNext

Break down the EMG.L vs PFE comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar valuation-driven comparisons

Explore how EMG.L and PFE each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.